top of page

Videnskabelige studier om mRNA

Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine A Case Report and Mechanism of Action

Anafylaksi

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer BioNTech mRNA COVID-19 vaccine

Anafylaksi

IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines

Anafylaksi

High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers a secondary analysis of initial post-approval safety data

Anafylaksi

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan The First-Month Report

Anafylaksi

COVID-19 vaccines increase the risk of anaphylaxis

Anafylaksi

COVID-19 vaccine-associated anaphylaxis A statement of the World Allergy Organization Anaphylaxis Committee

Anafylaksi

Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result

Anafylaksi

Biphasic anaphylaxis after exposure to the first dose

Anafylaksi

Anaphylaxis associated with the mRNA COVID-19 vaccines Approach to allergy investigation

Anafylaksi

Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria

Anafylaksi

Anaphylaxis after Moderna COVID-19 vaccine

Anafylaksi

Anaphylactic reactions to mRNA COVID-19 vaccines A call for further study

Anafylaksi

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Anafylaksi

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020

Anafylaksi

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 202

Anafylaksi

Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021

Anafylaksi

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines

Anafylaksi

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

Allergic Reactions

Severe allergic reactions after COVID-19 vaccination with the Pfizer BioNTech vaccine in Great Britain and USA

Allergic Reactions
bottom of page